JAK inhibitor | dermcity 2/2

top of page

it's where dermatology lives

DERM. CITY 2 copy.png

5. 3822-EN_Square post-1260x126px_V02.jpg

Yellow & Black gradient online health services linkedin banner (2000 x 400 px).gif

New oral JAK inhibitor effective for moderate-to-severe AD

May 21, 20212 min read

New oral JAK inhibitor effective for moderate-to-severe AD

Recently published findings from clinical trials of the oral Janus kinase (JAK) inhibitor upadacitinib show it is highly effective in...

2

Featured Posts

Nominations for the 2024 Women in Dermatology Honour Roll closing soon

Invitation to participate: Skin of Colour nomenclature survey study

All Posts 1,441 postsNo categories yet.
General 226 postsNo categories yet.
Acne 43 postsNo categories yet.
Videos 354 postsNo categories yet.
News 392 postsNo categories yet.
Atopic Dermatitis 152 postsNo categories yet.
Psoriasis 151 postsNo categories yet.
Skin Cancer 198 postsNo categories yet.
Melasma 2 postsNo categories yet.
Patient care 62 postsNo categories yet.
Cosmetic 28 postsNo categories yet.
Rosacea 10 postsNo categories yet.
Skin Spectrum Summit 49 postsNo categories yet.
Clinical Practice 10 postsNo categories yet.

600x100 animated.gif

bottom of page